admin

Top Biotech Penny Stocks to Watch — July 7, 2021

So many potential plays in biotech penny stocks this week!

I love the volatility that allows me to profit 10%–20% per trade, not per year like investors.

And there’s tons of volatility this week. Even as the overall markets were off to an ugly start to the week, I traded safely and profited.*

Lots of news is driving this week’s biotech action…

Mergers, positive trial results, and institutional buying. Then there’s the patent news I traded and for 10% gain.* And I see future catalysts to watch for a few of these stocks.

Keep your eyes on these recent runners. They could offer more opportunities in the future…

Here are the top biotech penny stocks I’m watching this week and why.

Top Biotech Penny Stocks to Watch

These are the top stocks on my watchlist. ‘Watch’ is the key word here. There’s no guarantee that there’ll be a trading opportunity. Remember, these stocks move FAST.

Before we get to my list of stocks to watch, here are a few of my top resources for penny stocks…

How do I find hot stocks? I use StocksToTrade every day. For me, it’s the best tool because I helped design it specifically for trading penny stocks. (I’m also an investor.) It has awesome charts, built-in scans, social media feeds, and so much more to help you do your research.

And its Breaking News Chat add-on feature is a game-changer in this hot market. It helped me make record profits in 2020.* Get a StockToTrade 14-day trial for only $7…

Or try it with the Breaking News Chat for only $17!

Now, let’s get to the top biotech penny stocks to watch this week…

Biotech Penny Stocks #1: Advaxis, Inc. (NASDAQ: ADXS)

ADXS is a clinical-stage biotech company with drugs in various trial phases for different cancer treatments.

The stock was up 50% on July 6 after the company announced it entered into a merger agreement.

“Following the closing, which is expected to occur in the second half of 2021, Advaxis will be renamed Biosight Therapeutics and is expected to trade on the Nasdaq Capital Market under the ticker symbol ‘BSTX.’”

Read the full press release here.

I’ll watch for the stock to potentially continue higher. I’d like to see it break out above 76 cents.

 

Biotech Penny Stocks #2: Odonate Therapeutics, Inc. (NASDAQ: ODT)

ODT develops therapeutic cancer treatments.

The stock traded high volume on July 2 and 6 after SEC filings showed Ikarian Capital increased its stake in the company.

After the stock gapped up on July 6, it faded. I’ll watch for a panic dip-buy opportunity.

 

Biotech Penny Stocks #3: Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN)

DFFN develops therapies to increase the body’s ability to deliver oxygen to tissues.

The stock’s trading higher than average volume since the company announced positive Phase 1 trial results.

“In this trial, transcutaneous oxygen monitoring (‘TCOM’) was used to measure the direct pharmacodynamic effects of TSC on peripheral tissue oxygenation in healthy normal volunteers.

“Topline results were based upon analyses of primary endpoint data, which indicate, as compared to placebo, a positive dose-response trend in TCOM readings after TSC administration that persisted through the measurement period.”

Read the full press release here.

After the initial gap up following the news, the stock has been declining. It looks like it found support around 65 cents. I’ll watch for it to potentially bounce to the upside.

 

Biotech Penny Stocks #4: Regen BioPharma, Inc. (OTCPK: RGBP)

RGBP has plans to develop a treatment for cancers and autoimmune diseases by activating immune cells.

The stock spiked on July 2 after announcing its subsidiary’s patent.

I bought 385,600 shares at $0.0212. I considered holding over the weekend since promoters love to pump news over the weekend. But when it reached my goals, I sold at $0.0235. I made $887, or 10%, on the trade.*

After the long weekend, the stock gapped up and had a morning spike. I’ll watch it for a morning panic dip-buy opportunity.

 

Biotech Penny Stocks #5: Adial Pharmaceuticals, Inc. (NASDAQ: ADIL)

ADIL develops potential treatments for addiction disorders. It returns to the watchlist from last week.

The stock has been volatile and is trading between $2.25 and $3.75.

On July 6 the company announced that its Phase 3 clinical trial met its patient screening target and is close to achieving its patient enrollment target.

I’m watching it for a potential multi-day breakout over $3.

 

Biotech Penny Stocks #6: GlobeStar Therapeutics Corp. (OTCPK: SOAN)

SOAN develops dietary supplements for adult wellness.

The stock traded higher on July 6 after the company announced that FINRA approved the company’s name change, effective immediately.

The company was formerly named AngioSoma, Inc. and is now GlobeStar Therapeutics Corp. The ticker remains the same.

As part of the press release, the company announced a new website launch for later this month.

I’ll watch it potentially continue higher. With the right catalyst, it could break out to new 52-week highs over $0.089.

 

Biotech Penny Stocks #7: Axcella Health Inc. (NASDAQ: AXLA)

AXLA develops potential treatments for complex diseases.

The company’s most recent news is from June 30. That’s when AXLA announced it initiated Phase 2 clinical trials for its potential treatment for “the reduction in risk of recurrent overt hepatic encephalopathy (OHE).”

Read the full press release here.

The stock gapped up huge on July 6 with no news, then faded throughout the day. I’ll watch for a morning panic dip-buy opportunity.

 

Biotech Penny Stocks #8: Tauriga Sciences, Inc. (OTCQB: TAUG)

TAUG develops cannabinoid chewing gum and other CBD skincare products.

The stock was up on July 6 after the company announced that Amazon approved its Brand Registry application. The company is in the process of listing its products for sale on Amazon.

The press release hints that the company will issue another press release once the listing is complete.

That could be a future catalyst to watch. The stock will need high volume for a big move like it had in the past.

 

Biotech Penny Stocks #9: GeoVax Labs, Inc. (NASDAQ: GOVX)

GOVX develops immunotherapies and vaccines to fight infectious diseases.

On July 6, StocksToTrade Breaking News Chat** alerted that the company was granted a patent for “Compositions and methods for generating an immune response to hepatitis B virus.”

The stock spiked on the news but quickly tanked back to its pre-news levels. I’ll watch for it to potentially continue higher as the news spreads.

 

Biotech Penny Stocks #10: Institute of Biomedical Research Corp. (OTCPK: MRES)

MRES is a biomedical research and analytics company.

It was on my watchlist a few weeks ago after a Twitter pump on its updating company officers and contact information on OTCmarkets.com. The company is still listed as ‘dark or defunct’ on the OTC website.

The stock has held up near its highs but volume’s fading. I’ll watch it for a morning panic dip-buy opportunity.

 

Get the List of Penny Stocks I’m Watching Delivered to Your Inbox

Want to know which stocks I’m watching each week? Subscribe to my no-cost watchlist. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.

penny stock checklist

I’ll say it again … The stocks on my watchlist aren’t an automatic buy. Remember to do your own due diligence and research. If you’re trading without a trading plan, you’re gambling. Don’t be a degenerate gambler — trade smart!

👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.

Conclusion

Biotech penny stocks are stocks of small, developmental companies. These companies are usually desperate for cash. They need it to continue developing products and for testing and trials. Trade them with caution…

They’re known to be extremely volatile. They can have huge price swings. One minute they’re flying high on positive news — the next they’re down due to bad trial results, side effects, or stock dilution.

If you’re prepared to take advantage of the price swings, these stocks can offer great trading opportunities…

In my Trading Challenge chat room, my students and I talk about the hottest penny stocks. And many top traders who got their start in the Challenge are now chat moderators who answer questions and help out new students.

If you want to join a community of top traders, apply for my Trading Challenge. I don’t accept everyone. I only want the most dedicated students who are willing to put in the time and effort it takes to become my next top student. Could it be you?

What do you think of these biotech penny stocks to watch? Let me know in the comments … I love to hear from you!

Disclaimers

*Please note that these kinds of trading results are not typical and do not reflect the experience of the majority of individuals using our products. From January 1, 2020, to December 31, 2020, typical users of the products and services offered by this website reported earning, on average, an estimated $49.91 in profit. This figure is taken from tracking user accounts on Profit.ly, a trading community platform. It takes years of dedication, hard work, and discipline to learn how to trade. Individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.

**Tim Sykes has a minority ownership stake in StockstoTrade.com.

The post Top Biotech Penny Stocks to Watch — July 7, 2021 appeared first on Timothy Sykes.